We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

110 hedge funds and large institutions have $287M invested in BioDelivery Sciences International, Inc. in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 31 increasing their positions, 38 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

674% more call options, than puts

Call options by funds: $851K | Put options by funds: $110K

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

7% more funds holding

Funds holding: 103110 (+7)

5% more capital invested

Capital invested by funds: $273M → $287M (+$14.1M)

18% less repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 38

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
2.39%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
29
Increased
31
Reduced
38
Closed
21
Calls
$851K
Puts
$110K
Net Calls
+$741K
Net Calls Change
+$219K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$2.96M -$2.14M -460,594 -42%
PVI
27
Pura Vida Investments
New York
$2.91M -$350K -75,243 -11%
CCM
28
Cadence Capital Management
Massachusetts
$2.38M -$79.8K -17,134 -3%
N
29
Nuveen
North Carolina
$2.36M +$2.36M +507,107 New
Squarepoint
30
Squarepoint
New York
$2.29M +$953K +204,710 +71%
Millennium Management
31
Millennium Management
New York
$2.26M -$6.18M -1,328,500 -73%
PPA
32
Parametric Portfolio Associates
Washington
$2.23M +$1.14M +244,292 +104%
Ameriprise
33
Ameriprise
Minnesota
$2.23M -$1.14M -245,842 -34%
FCMI
34
Foresite Capital Management III
California
$2.11M -$815K -175,000 -28%
DMK
35
David M. Knott
$2.11M +$243K +52,302 +13%
EGI
36
EAM Global Investors
California
$1.95M
EIM
37
Essex Investment Management
Massachusetts
$1.86M -$264K -56,650 -12%
MSL
38
Mackay Shields LLC
New York
$1.7M +$1.7M +365,700 New
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.68M +$773K +165,934 +85%
EP
40
Eversept Partners
New York
$1.66M +$1.66M +356,274 New
USAA
41
United Services Automobile Association
Texas
$1.55M +$862K +185,200 +125%
CAM
42
ClariVest Asset Management
California
$1.51M -$746K -160,212 -33%
JP Morgan Chase
43
JP Morgan Chase
New York
$1.41M -$1.89M -405,378 -56%
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$1.4M +$1.4M +299,944 New
Citadel Advisors
45
Citadel Advisors
Florida
$1.36M +$577K +123,852 +73%
Jane Street
46
Jane Street
New York
$1.27M +$1.16M +248,584 +967%
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$1.23M +$28.1K +6,030 +2%
Northern Trust
48
Northern Trust
Illinois
$1.2M +$343K +73,637 +40%
Renaissance Technologies
49
Renaissance Technologies
New York
$1.08M -$705K -151,500 -39%
JGC
50
J. Goldman & Co
New York
$930K +$931K +200,000 New

BDSI Hedge Fund Activity: Q2 2019 in Review

110 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2019, worth a combined $287M — up 5.2% from $273M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new BDSI positions and 21 closed out — a net gain of 8 holders — while 31 added to existing stakes and 38 trimmed.

The largest buyer was BlackRock, adding an estimated $18.8M. The largest seller was Morgan Stanley, cutting an estimated $8.04M.

  • 110 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2019, up from 103 in Q1 2019.
  • Funds reported $287M of BioDelivery Sciences International, Inc. stock for Q2 2019, up 5.2% quarter-over-quarter.
  • 29 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2019 and 21 closed out, a net change of +8 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2019 was BlackRock, an estimated $18.8M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2019 was Morgan Stanley, an estimated $8.04M sold.

Based on aggregated 13F filings for Q2 2019.